Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Full Disclosure Trading -- Ignore unavailable to you. Want to Upgrade?

To: advocatedevil who wrote (1538)	8/2/2002 1:45:57 PM
From: advocatedevil	Read Replies (1) \| Respond to of 13403

Short AMAT DT 3000 averaged at $13.47 AdvocateDevil

To: advocatedevil who wrote (1538)	8/2/2002 1:46:22 PM
From: Return to Sender	Respond to of 13403

HGSI ST SS 1000 shares@16.07 - I'm taking a chance here that both the biotech index and HGSI topped out the last few days. These stocks are much more overbought than the semiconductors. HGSI has zero chance of being profitable any time soon but I could have got a better entry earlier today. stockcharts.com[h,a]daclyyay[pb50,200!d20,2!c20][vc60][iUb14!Uk14!La12,26,9]&pref=G stockcharts.com[h,a]daclyyay[pb50,200!d20,2!c20][vc60][iUb14!Uk14!La12,26,9]&pref=G BTK Components: finance.yahoo.com finance.yahoo.com From Briefing.com: Jul 25 2002 4:23 PM In Play Human Genome misses by a penny (HGSI) 14.91 +0.44: Reports Q2 loss of $0.36, $0.01 worse than the Multex consensus; sales were $642,000, vs consensus of $2.1 mln. The decrease in revenues is due to the expiration of the exclusive aspects of the co's Human Gene Consortium on June 30, 2001, which completed the Consortium members' initial payment obligations (it is unclear whether the rev consensus takes this expiration into account). I'm happy to see you safely scalped some bucks AD! RtS